Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.58p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.35
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 866,714
  • Market Cap: £2.15m
  • RiskGrade: 435

Latest ShareCast News

ValiRx launches prostate cancer subsidiary Blue Ribbon Bio

By Josh White

Date: Tuesday 26 Aug 2025

(Sharecast News) - ValiRx announced a new wholly owned subsidiary Blue Ribbon Bio on Tuesday, to consolidate its prostate cancer assets and accelerate development of its Val201 peptide therapy.

Ambrose exercises ValiRx oncology option worth up to £16m

By Josh White

Date: Friday 20 Jun 2025

(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth up to £16m plus royalties.

ValiRx terminates exclusive negotiations with TheoremRx

By Josh White

Date: Thursday 03 Apr 2025

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations originally set to run until 31 May.

ValiRx's Inaphaea inks deal with UK-based Screen... 03-Feb-2025 ShareCast
ValiRx enters evaluation and option deal with Ca... 29-Jan-2025 ShareCast
ValiRx further extends letter of intent with The... 31-Dec-2024 ShareCast
ValiRx shares tank on £1.6m fundraising plan to ... 09-Dec-2024 ShareCast
ValiRx subsidiary makes first sale 18-Nov-2024 ShareCast
ValiRx losses narrow in first half 27-Sep-2024 ShareCast
ValiRx pulls out of University of Barcelona coll... 26-Sep-2024 ShareCast
ValiRx subsidiary inks agreement with research f... 18-Sep-2024 ShareCast
ValiRx inks deal with Dundee Drug Discovery Unit 12-Feb-2024 ShareCast
ValiRx enters option deal with Ambrose Healthcare 05-Dec-2023 ShareCast
ValiRx enters partnership with StingRay Bio 10-Nov-2023 ShareCast
ValiRx shares jump as H1 losses shrink 24-Aug-2023 ShareCast
ValiRx subsidiary Inaphaea signs deal with Agili... 14-Aug-2023 ShareCast
ValiRx terminates collaboration with Hokkaido Un... 16-Jun-2023 ShareCast
ValiRx acquires assets of in-liquidation Imagen ... 14-Jun-2023 ShareCast
ValiRx incorporates new wholly-owned lab subsidi... 01-Mar-2023 ShareCast
ValiRx forms new majority-owned breast cancer su... 24-Oct-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.58p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.35
52 Week Low 0.42
Volume 866,714
Shares Issued 374.35m
Market Cap £2.15m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Price Trend
87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth
26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

Valirx Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
15:42 18,199 @ 0.57p
15:21 16,000 @ 0.63p
15:10 215 @ 0.65p
15:02 5,000 @ 0.65p
13:04 384,107 @ 0.65p

Valirx Key Personnel

CFO Gerald Desler

Top of Page